Disclaimer Regarding the Use of MRI Contrast Agents

MRI Master is an online platform created to assist MRI radiographers in understanding scanning techniques. It’s important to note that we do not provide prescriptions for medications or advice on their use or dosage. When determining the appropriate dosage of contrast material, it is recommended to follow the guidelines established by regulatory authorities such as the FDA, EMA, and the manufacturer.

Regulatory Authorities:

1. Food and Drug Administration (FDA): In the United States, the approval of MRI contrast agents falls under the jurisdiction of the FDA. The FDA regulates the safety and effectiveness of medical devices and drugs, including contrast agents used in MRI procedures. The FDA reviews applications from manufacturers, evaluating safety and efficacy data provided. If a contrast agent meets required standards, the FDA grants approval for its use in the US. For a list of FDA-approved MRI contrast agents, please refer to this link: FDA-Approved MRI Contrast Agents

2. European Medicines Agency (EMA): In Europe, the EMA oversees the approval and regulation of MRI contrast agents. The EMA evaluates and grants authorization for medicinal products within the European Union. For a list of EMA-approved MRI contrast agents, please refer to this link: EMA-Approved MRI Contrast Agents

For more detailed information on gadolinium-containing contrast agents, you can access the referral assessment report from the European Medicines Agency: EMA Referral Assessment Report

Specific Contrast Agents:

Please note that this information is subject to change, and it is recommended to consult the provided links for the most up-to-date prescribing information.

General Information: The information provided on is intended for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before using any medication.

Medical Professional Oversight: The administration of Substances during MRI examinations should be carried out under the supervision of qualified medical professionals. The responsibility for determining the appropriateness of using these Substances for an individual patient lies with the medical practitioner or healthcare provider.

Professional Responsibility:

Healthcare professionals and practitioners are solely responsible for determining the appropriateness of using these Medications for specific patients, based on their medical condition and other relevant factors.

Website References:

The provided website references are for informational purposes only. Users are responsible for ensuring that they have the most up-to-date and accurate information from reliable sources.

Liability Waiver:

The operators of and its affiliates shall not be held liable for any adverse effects, consequences, or liabilities arising from the use of these Medications in MRI examinations.

Disclaimer: The information provided in these terms and conditions is based on the references mentioned and should not replace professional medical advice. Always consult a qualified healthcare provider before using any contrast agents or medications. The administrators of are not liable for any misuse, misinterpretation, or adverse effects resulting from the use of these contrast agents.